Virus - Revision history

Michael: chg redirect

2011-11-15T05:18:07Z

chg redirect

Michael: /* Epstein-Barr virus */ +polyoma virus

2011-11-15T04:58:10Z

Epstein-Barr virus: +polyoma virus

← Older revision		Revision as of 04:58, 15 November 2011
Line 163:		Line 163:
	**+/-Atypical lymphocytes.		**+/-Atypical lymphocytes.
	**+/-Hemophagocytosis (uncommon).		**+/-Hemophagocytosis (uncommon).

			==Polyomavirus==
			May refer to:
			#BK virus.
			#*See: ''[[Renal_transplant_pathology#Polyomavirus]]'' and ''[[Urine_cytopathology#Human_polyoma_infection]].
			#Merkel cell polyomavirus.
			#*See: ''[[Merkel cell carcinoma]]''.

	=See also=		=See also=

Michael: /* General */

2011-10-23T02:05:57Z

General

← Older revision		Revision as of 02:05, 23 October 2011
Line 145:		Line 145:
	*Abbreviated ''EBV''		*Abbreviated ''EBV''
	===General===		===General===
	*Cases mononucleosis.		*Cases [[mononucleosis]].
	*Part of the herpes group of viruses.<ref>URL: [http://www.meddean.luc.edu/lumen/MedEd/orfpath/herpes.htm http://www.meddean.luc.edu/lumen/MedEd/orfpath/herpes.htm]. Accessed on: 14 April 2011.</ref>		*Part of the herpes group of viruses.<ref>URL: [http://www.meddean.luc.edu/lumen/MedEd/orfpath/herpes.htm http://www.meddean.luc.edu/lumen/MedEd/orfpath/herpes.htm]. Accessed on: 14 April 2011.</ref>

Michael: /* Human papilloma virus */

2011-10-04T00:28:38Z

Human papilloma virus

← Older revision		Revision as of 00:28, 4 October 2011
Line 77:		Line 77:
	*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/>		*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/>

	Recombinant vaccine (Gardasil, Silgard) - ~~cover~~:<ref name=pmid21942919>{{Cite journal \| last1 = McCormack \| first1 = PL. \| last2 = Joura \| first2 = EA. \| title = Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†. \| journal = BioDrugs \| volume = 25 \| issue = 5 \| pages = 339-43 \| month = Oct \| year = 2011 \| doi = 10.2165/11205060-000000000-00000 \| PMID = 21942919 }}</ref>		Recombinant vaccine (Gardasil, Silgard) - covers:<ref name=pmid21942919>{{Cite journal \| last1 = McCormack \| first1 = PL. \| last2 = Joura \| first2 = EA. \| title = Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†. \| journal = BioDrugs \| volume = 25 \| issue = 5 \| pages = 339-43 \| month = Oct \| year = 2011 \| doi = 10.2165/11205060-000000000-00000 \| PMID = 21942919 }}</ref>
	*HPV 6.		*HPV 6.
	*HPV 11.		*HPV 11.

Michael: /* Human papilloma virus */ +vaccine

2011-10-04T00:28:17Z

Human papilloma virus: +vaccine

← Older revision		Revision as of 00:28, 4 October 2011
Line 76:		Line 76:
	*HPV 18 - predominantly adenocarcinoma.<ref name=pmid15551313>{{Cite journal \| last1 = De Boer \| first1 = MA. \| last2 = Peters \| first2 = LA. \| last3 = Aziz \| first3 = MF. \| last4 = Siregar \| first4 = B. \| last5 = Cornain \| first5 = S. \| last6 = Vrede \| first6 = MA. \| last7 = Jordanova \| first7 = ES. \| last8 = Fleuren \| first8 = GJ. \| title = Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. \| journal = Int J Cancer \| volume = 114 \| issue = 3 \| pages = 422-5 \| month = Apr \| year = 2005 \| doi = 10.1002/ijc.20727 \| PMID = 15551313 }}</ref>		*HPV 18 - predominantly adenocarcinoma.<ref name=pmid15551313>{{Cite journal \| last1 = De Boer \| first1 = MA. \| last2 = Peters \| first2 = LA. \| last3 = Aziz \| first3 = MF. \| last4 = Siregar \| first4 = B. \| last5 = Cornain \| first5 = S. \| last6 = Vrede \| first6 = MA. \| last7 = Jordanova \| first7 = ES. \| last8 = Fleuren \| first8 = GJ. \| title = Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. \| journal = Int J Cancer \| volume = 114 \| issue = 3 \| pages = 422-5 \| month = Apr \| year = 2005 \| doi = 10.1002/ijc.20727 \| PMID = 15551313 }}</ref>
	*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/>		*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/>

			Recombinant vaccine (Gardasil, Silgard) - cover:<ref name=pmid21942919>{{Cite journal \| last1 = McCormack \| first1 = PL. \| last2 = Joura \| first2 = EA. \| title = Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†. \| journal = BioDrugs \| volume = 25 \| issue = 5 \| pages = 339-43 \| month = Oct \| year = 2011 \| doi = 10.2165/11205060-000000000-00000 \| PMID = 21942919 }}</ref>
			*HPV 6.
			*HPV 11.
			*HPV 16.
			*HPV 18.

	===Microscopic===		===Microscopic===

Michael: /* Human papilloma virus */ +16 18

2011-10-04T00:24:48Z

Human papilloma virus: +16 18

← Older revision		Revision as of 00:24, 4 October 2011
Line 72:		Line 72:
	***Anal cancer and precurors ([[Anus#Anal_intraepithelial_neoplasia\|AIN]])		***Anal cancer and precurors ([[Anus#Anal_intraepithelial_neoplasia\|AIN]])
	***Squamous cell carcinoma in the [[Head & neck pathology\|head & neck]].		***Squamous cell carcinoma in the [[Head & neck pathology\|head & neck]].

			Oncocytic types:
			*HPV 18 - predominantly adenocarcinoma.<ref name=pmid15551313>{{Cite journal \| last1 = De Boer \| first1 = MA. \| last2 = Peters \| first2 = LA. \| last3 = Aziz \| first3 = MF. \| last4 = Siregar \| first4 = B. \| last5 = Cornain \| first5 = S. \| last6 = Vrede \| first6 = MA. \| last7 = Jordanova \| first7 = ES. \| last8 = Fleuren \| first8 = GJ. \| title = Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. \| journal = Int J Cancer \| volume = 114 \| issue = 3 \| pages = 422-5 \| month = Apr \| year = 2005 \| doi = 10.1002/ijc.20727 \| PMID = 15551313 }}</ref>
			*HPV 16 - predominantly squamous cell carcinoma.<ref name=pmid15551313/>

	===Microscopic===		===Microscopic===

Michael: /* Microscopic */ fix sp.

2011-09-11T04:32:02Z

Microscopic: fix sp.

← Older revision		Revision as of 04:32, 11 September 2011
Line 125:		Line 125:
	Images:		Images:
	*[[WC]]:		*[[WC]]:
	**[http://commons.wikimedia.org/wiki/File:Parvovirus_infection_-_cropped_2_-_very_high_mag.jpg ~~Parovirus~~ - version 1 - very high mag. (WC)].		**[http://commons.wikimedia.org/wiki/File:Parvovirus_infection_-_cropped_2_-_very_high_mag.jpg Parvovirus - version 1 - very high mag. (WC)].
	**[http://commons.wikimedia.org/wiki/File:Parvovirus_infection_-_cropped_1_-_very_high_mag.jpg Parvovirus - version 2 - very high mag. (WC)].		**[http://commons.wikimedia.org/wiki/File:Parvovirus_infection_-_cropped_1_-_very_high_mag.jpg Parvovirus - version 2 - very high mag. (WC)].
	*www:		*www:

Michael: /* Cytomegalovirus */

2011-09-11T04:31:37Z

Cytomegalovirus

← Older revision		Revision as of 04:31, 11 September 2011
Line 54:		Line 54:
	Images:		Images:
	*[http://commons.wikimedia.org/wiki/File:CMV_placentitis2_mini.jpg CMV placentitis (WC)].		*[http://commons.wikimedia.org/wiki/File:CMV_placentitis2_mini.jpg CMV placentitis (WC)].
			*[http://www.asm.org/division/c/photo/cmv1.jpg CMV (asm.org)].

	===IHC===		===IHC===

Michael: /* Human papilloma virus */

2011-08-28T04:01:13Z

Human papilloma virus

← Older revision		Revision as of 04:01, 28 August 2011
Line 68:		Line 68:
	***[[Esophagus#Human_papilloma_virus_esophagitis\|HPV esophagitis]].		***[[Esophagus#Human_papilloma_virus_esophagitis\|HPV esophagitis]].
	**Malignant:		**Malignant:
	***[[Uterine cervix\|Cervical cancer]].		***[[Uterine cervix\|Cervical cancer]] and precursors ([[LSIL]], [[HSIL]]).
	***Anal cancer.		***Anal cancer and precurors ([[Anus#Anal_intraepithelial_neoplasia\|AIN]])
	***Squamous cell carcinoma in the [[Head & neck pathology\|head & neck]].		***Squamous cell carcinoma in the [[Head & neck pathology\|head & neck]].

Michael: /* Human papilloma virus */

2011-08-28T03:57:17Z

Human papilloma virus

← Older revision		Revision as of 03:57, 28 August 2011
Line 70:		Line 70:
	***[[Uterine cervix\|Cervical cancer]].		***[[Uterine cervix\|Cervical cancer]].
	***Anal cancer.		***Anal cancer.
			***Squamous cell carcinoma in the [[Head & neck pathology\|head & neck]].

	===Microscopic===		===Microscopic===